RAVEEN MEHENDRU: Open Payments
NPI 1174565253 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 10 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $329 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Indivior Inc. | 1 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: COBENFY, REXULTI, INGREZZA, SUBLOCADE, INVEGA SUSTENNA, UZEDY, FANAPT.
Industry payments across CT — which companies pay providers there.
